Moreover, an analysis of the combined effects of LPAL2 and MMP9 showed that survival outcomes were better in HCC patients with a higher expression of LPAL2 and lower expression of MMP9 than in other groups. The gene discussed is LPAL2; the disease is hepatocellular carcinoma.